Kura Oncology(KURA)
$7.49+0.40 (+5.64%)
KURA
Kura Oncology ownership
$7.49
At close:+0.40 (+5.64%)
Want to see KURA full AI Analyst Report?
Kura Oncology (KURA) Ownership - Who Owns Kura Oncology?
974 Followers
Kura Oncology (KURA) Ownership Overview
- 2.59% Insiders
- 11.05% Mutual Funds
- 47.29% Other Institutional Investors
- 16.36% ETFs
- 22.70% Public Companies and Individual Investors
The ownership structure of Kura Oncology (KURA) stock is a mix of institutional, retail, and individual investors. Approximately 74.70% of the company’s stock is owned by Institutional Investors, 2.59% is owned by Insiders, and 22.70% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Kura Oncology (KURA) stock is a mix of institutional, retail, and individual investors. Approximately 74.70% of the company’s stock is owned by Institutional Investors, 2.59% is owned by Insiders, and 22.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 15, 2026 | Troy Edward Wilson | $1,504,765 | |
| Sep 28, 2026 | Kathleen Ford | $72,444 | |
| Sep 28, 2026 | Teresa Brophy Bair | $88,557 | |
| Sep 28, 2026 | Mollie Leoni | $130,580 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Woodline Partners Lp | $2,824,270 | |
| Sep 30, 2026 | $125,938,665 | ||
| Sep 30, 2026 | Entrypoint Capital, Llc | $121,537 | |
| Sep 30, 2026 | Fisher Asset Management Llc | $6,054,363 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 11,758,979 | Institution | 12.80% | 83,371,161 |
| Ishares | 4,706,859 | Institution | 5.12% | 33,371,630 |
| Vanguard | 4,636,230 | Institution | 5.05% | 32,870,871 |
| Vanguard Index Funds | 3,826,281 | Institution | 4.16% | 27,128,332 |
| Spdr | 2,966,630 | Institution | 3.23% | 21,033,407 |
| Troy Edward Wilson | 1,414,650 | Insider | 1.54% | 10,029,869 |
| Fidelity Salem Street Trust | 1,022,335 | Institution | 1.11% | 7,248,355 |
| Fidelity Concord Street Trust | 884,005 | Institution | 0.96% | 6,267,595 |
| Chuck Royce | 658,811 | Institution | 0.72% | 4,670,970 |
| Blackrock Funds | 653,639 | Institution | 0.71% | 4,634,301 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,826,281 | Institution | 4.16% | 27,128,332 |
| Fidelity Salem Street Trust | 1,022,335 | Institution | 1.11% | 7,248,355 |
| Fidelity Concord Street Trust | 884,005 | Institution | 0.96% | 6,267,595 |
| Blackrock Funds | 653,639 | Institution | 0.71% | 4,634,301 |
| Dfa Investment Dimensions Group Inc | 592,987 | Institution | 0.65% | 4,204,278 |
| Vanguard Scottsdale Funds | 588,069 | Institution | 0.64% | 4,169,409 |
| Tiaa-cref Funds | 301,598 | Institution | 0.33% | 2,138,330 |
| Vanguard Horizon Funds | 300,321 | Institution | 0.33% | 2,129,276 |
| Vanguard Explorer Fund | 245,051 | Institution | 0.27% | 1,737,412 |
| Exchange Place Advisors Trust | 240,434 | Institution | 0.26% | 1,704,677 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| SPDR S&P BIOTECH ETF, XBI ETF | 2,665,590 | Institution | 2.90% | 20,711,634 |
| iShares Russell 2000 ETF, IWM ETF | 2,222,434 | Institution | 2.42% | 17,268,312 |
| Vanguard Total Stock Market ETF, VTI ETF | 2,115,003 | Institution | 2.30% | 21,699,931 |
| Vanguard Extended Market ETF, VXF ETF | 1,022,231 | Institution | 1.11% | 10,488,090 |
| iShares Russell 2000 Growth ETF, IWO ETF | 796,345 | Institution | 0.87% | 6,187,601 |
| iShares Biotechnology ETF, IBB ETF | 668,814 | Institution | 0.73% | 4,741,891 |
| Fidelity Enhanced Small Cap ETF, FESM ETF | 550,202 | Institution | 0.60% | 4,275,070 |
| Vanguard Russell 2000 ETF, VTWO ETF | 500,771 | Institution | 0.55% | 5,137,910 |
| Schwab U.S. Small-Cap ETF, SCHA ETF | 477,091 | Institution | 0.52% | 3,706,997 |
| iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund, IDNA ETF | 267,028 | Institution | 0.29% | 1,893,229 |
FAQ
Who Owns Kura Oncology (KURA)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 74.70% of the company's stock is held by institutional investors, 2.59% is held by insiders, and 22.70% is held by public companies and individual investors.
What percentage of Kura Oncology (KURA) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 74.70% of Kura Oncology (KURA) stock is held by institutional investors: 11.05% by mutual funds, 16.36% by ETFs and 47.29% by other institutional investors.
What percentage of Kura Oncology (KURA) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 22.70% of Kura Oncology (KURA) stock is held by public companies and individual investors.
Who owns the most shares of Kura Oncology (KURA)?
BlackRock, Inc. owns the most shares of Kura Oncology (KURA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

